Who Partnered With Us in 2025?
Expertise Partners:
myTomorrows
myTomorrows is a global health tech company dedicated to helping patients and physicians discover and access treatment options. We have partnered with 50+ Biopharma companies to support end-to-end expanded access program delivery, generate real-world data, and streamline clinical trial recruitment through the use of our proprietary AI technology. Our proactive, and stakeholder-focused approach combined with our operational excellence, innovation and adaptability ensures the best possible outcomes for patients, physicians, and our partners.
WEP
At WEP, we are With Every Patient, as we believe every patient should have access to treatment. With this as our guiding principle, we operate as a Complete CRO committed to delivering Clinical Trials, Expanded Access Programs, and Commercialization Solutions for Sponsors and patients worldwide. Our programs are delivered through High Quality, High Service, and High Value, returning a positive ROI to all Sponsors we have partnered with.
Event Partners:
Bionical Emas
Bionical Emas is a global Early Access Programs (EAP) specialist bringing life-changing medicines to patients around the world. Their comprehensive suite of services and capabilities benefit many of the world’s leading pharma and biotech companies.
Bionical Emas provides in-house, highly specialized and EAP centric clinical services, including dedicated Real-World Evidence, Pharmacovigilance and Medical teams to support all program requirements. Their vast experience in oncology and rare disease, and dedicated EAP teams and processes, are essential to providing innovative EAP solutions to pharma and biotech companies globally.
With a truly patient-focused approach, Bionical Emas offers a best-in-class EAP service that ensures patient, healthcare professional, and client needs are met through passionate and tailored program delivery.
Inceptua Early Access
Inceptua Early Access is a global company specialising in the provision of Early Access Programs. With offices in 5 EU countries, the US, China and Japan, and a sophisticated global network of warehousing and shipping, Inceptua can supply medicines anywhere in the world. Inceptua has deep expertise in the setting up and running of complex group programs, post-trial access programs, exclusive distribution arrangements and market withdrawal scenarios. Our highly experienced management team provide unparalleled guidance and consulting services to support our clients in getting their medicines to patients in need, wherever they may be.
MedaSystems
MedaSystems' software is trusted by pharmaceutical companies across the United States and Europe to enhance patient outcomes and streamline the management of drugs under various pre-approval access pathways. Numerous major academic institutions actively use it, and our research and development efforts are grounded in thousands of hours spent collaborating with experts in global pre-approval access.
Life Science Companies use MedaSystems to:
- Easily collaborate with healthcare providers
- Make approval decisions faster
- Reduce frustrating repetitive manual steps
- Capture real-world data
- Comply with regulations
